{"nbformat": 4, "nbformat_minor": 5, "cells": [{"cell_type": "markdown", "metadata": {}, "source": "This notebook will analyze acylcarnitine levels in cystic fluid samples from patients with varying risk levels of IPMN."}, {"cell_type": "code", "outputs": [], "metadata": {}, "execution_count": null, "source": "import pandas as pd\nimport matplotlib.pyplot as plt\n\n# Load dataset\ndata = pd.read_csv('acylcarnitine_levels.csv')\n\n# Analyze acylcarnitine levels\nhigh_risk = data[data['risk'] == 'high']\nlow_risk = data[data['risk'] == 'low']\n\n# Plotting\nplt.figure(figsize=(10,6))\nplt.boxplot([high_risk['acylcarnitine_levels'], low_risk['acylcarnitine_levels']], labels=['High Risk', 'Low Risk'])\nplt.title('Acylcarnitine Levels in IPMN Patients')\nplt.ylabel('Acylcarnitine Levels')\nplt.show()"}, {"cell_type": "markdown", "metadata": {}, "source": "This analysis will help visualize the differences in acylcarnitine levels between high-risk and low-risk IPMN patients."}, {"cell_type": "code", "outputs": [], "metadata": {}, "execution_count": null, "source": "# Further analysis can include statistical tests to validate differences."}, {"cell_type": "markdown", "metadata": {}, "source": "\n\n\n\n***\n### [**Evolve This Code**](https://biologpt.com/?q=Evolve%20Code%3A%20Analyze%20acylcarnitine%20profiles%20in%20IPMN%20samples%20to%20identify%20metabolic%20signatures%20associated%20with%20malignancy.%0A%0AIncorporate%20additional%20datasets%20for%20a%20more%20comprehensive%20analysis%20of%20metabolic%20profiles.%0A%0ALong-chain%20acylcarnitines%20mitochondrial%20reprogramming%20IPMNs%20malignant%20transformation%0A%0AThis%20notebook%20will%20analyze%20acylcarnitine%20levels%20in%20cystic%20fluid%20samples%20from%20patients%20with%20varying%20risk%20levels%20of%20IPMN.%0A%0Aimport%20pandas%20as%20pd%0Aimport%20matplotlib.pyplot%20as%20plt%0A%0A%23%20Load%20dataset%0Adata%20%3D%20pd.read_csv%28%27acylcarnitine_levels.csv%27%29%0A%0A%23%20Analyze%20acylcarnitine%20levels%0Ahigh_risk%20%3D%20data%5Bdata%5B%27risk%27%5D%20%3D%3D%20%27high%27%5D%0Alow_risk%20%3D%20data%5Bdata%5B%27risk%27%5D%20%3D%3D%20%27low%27%5D%0A%0A%23%20Plotting%0Aplt.figure%28figsize%3D%2810%2C6%29%29%0Aplt.boxplot%28%5Bhigh_risk%5B%27acylcarnitine_levels%27%5D%2C%20low_risk%5B%27acylcarnitine_levels%27%5D%5D%2C%20labels%3D%5B%27High%20Risk%27%2C%20%27Low%20Risk%27%5D%29%0Aplt.title%28%27Acylcarnitine%20Levels%20in%20IPMN%20Patients%27%29%0Aplt.ylabel%28%27Acylcarnitine%20Levels%27%29%0Aplt.show%28%29%0A%0AThis%20analysis%20will%20help%20visualize%20the%20differences%20in%20acylcarnitine%20levels%20between%20high-risk%20and%20low-risk%20IPMN%20patients.%0A%0A%23%20Further%20analysis%20can%20include%20statistical%20tests%20to%20validate%20differences.%0A%0A)\n***\n\n### [Created with BioloGPT](https://biologpt.com/?q=Novel%20hypothesis%3A%20Could%20reduced%20levels%20of%20long-chain%20acylcarnitines%20in%20high-risk%20IPMNs%20reflect%20mitochondrial%20reprogramming%20as%20an%20early%20indicator%20of%20malignant%20transformation)\n[![BioloGPT Logo](https://biologpt.com/static/icons/bioinformatics_wizard.png)](https://biologpt.com/)\n***"}], "metadata": {"title": "Analyze acylcarnitine profiles in IPMN samples to identify metabolic signatures associated with malignancy.", "kernelspec": {"display_name": "Python 3", "language": "python", "name": "python3"}, "language_info": {"name": "python", "version": "3.13", "mimetype": "text/x-python", "codemirror_mode": {"name": "ipython", "version": 3}, "file_extension": ".py", "pygments_lexer": "ipython3"}, "author": "BioloGPT", "creation_date": "2025-03-03", "tags": ["long-chain acylcarnitines IPMNs", "biology", "bioinformatics"]}}